An observational study in Transfusion Reaction, Transfusion Related Complication and Anesthesia, sponsored by Erasme University Hospital. Recruiting at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2025-09-02.
Sponsored by Erasme University Hospital · Observational
the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.
the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.
Patients will be informed at the time of the anaesthesia consultation about the inclusion in the registry.
The data will be collected from the patients' files by the investigators of the centre without modifying their management.
The data collection period will not exceed the period of acute management.
56 studies on the registry are indexed under Transfusion Reaction; 12 are open to participants now.
This study's planned enrollment of 50,000 is above the median of 387 across 26 observational studies indexed under Transfusion Reaction.
Browse Transfusion Reaction studies →Erasme University Hospital is the lead sponsor of 181 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patient who received an hemostasis product during an hemorrhagic situation
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients who received an hemostatic product
Procedure: Transfusion
Transfusion of an hemostatic product
Hemostatic evolution through transfusion event
evolution of APTT (seconds)
Time frame: 12 hours
ROTEM measures evolution through transfusion event
evolution of APTEMCT (seconds)
Time frame: 12 hours
Haematologic measures evolution through transfusion event
evolution of hemoglobin (g/dL)
Time frame: 12 hours
ionic measures evolution through transfusion event
evolution of lactate (mmol/L)
Time frame: 12 hours
Mortality at one month
Mortality at one month
Time frame: one month
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.